Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 9.05 | 4.75 | 9.18 | 4.10 |
Depreciation/ Depletion | 10.07 | 9.13 | 9.04 | 9.52 |
Non- Cash Items | 12.27 | 12.31 | 8.11 | 11.62 |
Changesin Working Capital | -8.58 | -28.03 | 0.46 | -3.46 |
Cashfrom Operating Activities | 22.81 | -1.84 | 26.80 | 21.78 |
Capital Expenditures | -10.98 | -14.65 | -8.47 | -3.41 |
Other Investing Cash Flow Items Total | -7.91 | -7.54 | -1.02 | -1.57 |
Cashfrom Investing Activities | -18.89 | -22.18 | -9.48 | -4.98 |
Financing Cash Flow Items | -17.05 | -12.90 | -9.49 | -8.65 |
Total Cash Dividends Paid | -1.57 | -1.56 | -1.48 | 0.00 |
Issuance( Retirement)of Stock Net | 1.23 | 3.44 | 0.00 | 0.94 |
Issuance( Retirement)of Debt Net | 16.19 | 35.42 | -6.25 | -8.92 |
Cashfrom Financing Activities | -1.21 | 24.40 | -17.22 | -16.63 |
Net Changein Cash | 2.71 | 0.37 | 0.09 | 0.16 |
Cash Interest Paid | 16.33 | 13.38 | 10.40 | 11.61 |
Cash Taxes Paid | 4.54 | 0.50 | 1.20 | 0.11 |
Foreign Exchange Effects | - | 0.00 | - | 0.00 |
Bal Pharma Dividend Bal Pharma Bonus Bal Pharma News Bal Pharma AGM Bal Pharma Rights Bal Pharma Splits Bal Pharma Board Meetings Bal Pharma Key Metrics Bal Pharma Shareholdings Bal Pharma Profit Loss Bal Pharma Balance Sheet Bal Pharma Q1 Results Bal Pharma Q2 Results Bal Pharma Q3 Results Bal Pharma Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks